Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Certified by Founder
Lodge
Company Ventures
investor
United States
- New York, New York
- 15/11/2022
- Seed
- $5,400,000
Company Ventures is an early-stage venture capital firm in NYC that provides a foundation for entrepreneurs building with purpose. In addition to investing in pre-seed/seed companies, Company Ventures operates the Grand Central Tech Residency, an annual program purposefully built to support NYC’s premier founding teams. The program provides rent-free space in our 1M sq. ft. midtown NYC tech campus to 25 startups per year with no equity requirement. Since the program’s inception in 2014, 127 program companies have raised $1.9B from top VCs.
- Industry Venture Capital and Private Equity Principals
- Website http://companyventures.co/
- LinkedIn https://www.linkedin.com/company/company-ventures/
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)